Blackford signs collaboration deal with Bayer

Company receives funding and support for the development of innovative digital health solutions Blackford has been announced as one of a select few compani

post image

Company receives funding and support for the development of innovative digital health solutions

Blackford has been announced as one of a select few companies chosen for Bayer’s G4A Digital Health Partnership program, focused on innovative digital health solutions designed to improve patient outcomes. “Our company’s “G4A Digital Health Partnerships” program paves the road for longer-term collaborations through which both parties can bring to market new solutions at the intersection of health and technology,” said Dr Zsuzsanna Varga, head of Bayer G4A Digital Health Partnerships program. Competition for the program was fierce, with Bayer receiving 750 applications from 65 countries. In the end, just 11 companies were chosen. Blackford was admitted to the program’s Advance Track, which supports companies looking to co-create and execute commercial deals. “We are delighted to have been recognized by Bayer as a mature digital health company with technology that improves patient health,” said Blackford CEO Ben Panter. “To be one of such a small number of companies chosen is a huge validation of our mission to improve efficiency and productivity in healthcare.” You can read the full press release here.